|
CMV Infected Cell Extract Lot G0628030 |
|
|
|
| Catalog Number |
CV001-1 1 ml |
|
|
| |
CV001-25 25 ml |
|
| |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
Lot Number |
G0628030 |
|
Expiration Date |
July 2009 |
|
|
|
Virus Strain
Host Cell
Cell Line Characterization
Purity
Inactivation
Supplied in
Protein Concentration
Fill Volume
ELISA (IgG) Titer
Western Blot Titer
Reference and/or Additional Reading |
|
AD169
Normal Human Dermal Fibroblast (NHDF)
Confirmed Negative for HIV and Hepatitis B
Infected cell extract enriched for viral proteins
Verified by tissue culture infectivity assay.
100 mM Glycine pH 9.5
0.53 mg/ml
1.03 ml (CV001-1) or 25.2 ml (CV001-25)
>1:1600
10 µg/cm
J. Infectious Diseases (1987), 156(4):615 |
| |
|
|
| |
|
|
ELISA Results
Antigen is Virusys # CV001 CMV Infected Cell Extract coated at various dilutions in PBS. Primary antibodies (CM01 - CM08) are human plasmas previously characterized for CMV IgG serology.
|
|
|
|
Western Blot Results
Antigen is Virusys # CV001 CMV Infected Cell Extract at 10 µg/cm. Primary antibodies (CM01 - CM08) are human plasmas previously characterized for CMV IgG serology.
|
|
|
| |
|
This product is intended for research and manufacturing uses only. It is not a diagnostic device. It is supplied frozen on dry ice - upon receipt, store at -70°C. Product degradation will result from multiple freeze/thaw cycles. It is suggested that the antigen be stored in use size aliquots and thawed just prior to use. Storage at 2 - 8°C for up to twelve hours is acceptable for unused portions. |
|
